NVDA

108.99

+3.43%↑

AVGO.US

188.02

+1.61%↑

ORCL

137.42

+1.19%↑

ASML.US

669.89

-0.11%↓

CRM

266.75

+1.9%↑

NVDA

108.99

+3.43%↑

AVGO.US

188.02

+1.61%↑

ORCL

137.42

+1.19%↑

ASML.US

669.89

-0.11%↓

CRM

266.75

+1.9%↑

NVDA

108.99

+3.43%↑

AVGO.US

188.02

+1.61%↑

ORCL

137.42

+1.19%↑

ASML.US

669.89

-0.11%↓

CRM

266.75

+1.9%↑

NVDA

108.99

+3.43%↑

AVGO.US

188.02

+1.61%↑

ORCL

137.42

+1.19%↑

ASML.US

669.89

-0.11%↓

CRM

266.75

+1.9%↑

NVDA

108.99

+3.43%↑

AVGO.US

188.02

+1.61%↑

ORCL

137.42

+1.19%↑

ASML.US

669.89

-0.11%↓

CRM

266.75

+1.9%↑

Search

Genpact Ltd

Atidarymo kaina

SektoriusTechnologijų sektorius

47.8 -0.19

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

47.21

Max

47.97

Pagrindiniai rodikliai

By Trading Economics

Pajamos

9.1M

142M

Pardavimai

38M

1.2B

P/E

Sektoriaus vid.

16.379

86.529

Pelnas, tenkantis vienai akcijai

0.91

Dividendų pajamingumas

1.43

Pelno marža

11.365

Darbuotojai

140,000

EBITDA

22M

228M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+17.57% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.43%

2.52%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-340M

8.2B

Ankstesnė atidarymo kaina

47.99

Ankstesnė uždarymo kaina

47.8

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Genpact Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-03-13 06:45; UTC

Uždarbis

Generali Operating Profit Rises on Higher Premiums

2025-04-22 10:57; UTC

Rinkos pokalbiai

Generali Shareholder Norges to Vote in Favor of Board Reappointment -- Market Talk

2025-04-10 08:53; UTC

Rinkos pokalbiai

Proxy Advisor Glass Lewis Backs Generali Board Reappointment -- Market Talk

2025-04-07 11:08; UTC

Rinkos pokalbiai

Renewal of Generali Board Supported by Proxy ISS -- Market Talk

2025-04-01 13:31; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

European Insurers Will Be Slower Than Banks to Consolidate, Generali Executive Says -- Interview

2025-04-01 13:31; UTC

Įsigijimai, susijungimai, perėmimai

Trends in European Insurance Are Fundamentally Positive, Consumer Demand Is Strong, Terzariol Says

2025-04-01 13:31; UTC

Įsigijimai, susijungimai, perėmimai

Smaller Insurance Players Might Become M&A Targets if Conditions Become Challenging, Terzariol Says

2025-04-01 13:30; UTC

Įsigijimai, susijungimai, perėmimai

Fewer European Insurers Will Be Around in 10, 20 Years, Generali's Terzariol Says

2025-04-01 13:30; UTC

Įsigijimai, susijungimai, perėmimai

European Insurers to Consolidate at Gradual Pace, Generali's Insurance Chief Says

2025-04-01 08:09; UTC

Rinkos pokalbiai

Generali's Board Tussle Is Main Risk for Shares -- Market Talk

2025-04-01 07:52; UTC

Rinkos pokalbiai
Uždarbis

European Insurers Liked by North American Investors -- Market Talk

2025-03-31 08:09; UTC

Rinkos pokalbiai

Mediobanca's List for Generali's Board Likely to Be Supported, Equita Says -- Market Talk

2025-03-13 08:00; UTC

Rinkos pokalbiai
Uždarbis

Generali's Dividend Growth Stands Out -- Market Talk

2025-03-13 07:57; UTC

Rinkos pokalbiai
Uždarbis

Generali's Results Look Solid -- Market Talk

2025-03-13 06:07; UTC

Uždarbis

Generali Backs 2025-27 Targets

2025-03-13 06:05; UTC

Uždarbis

Generali End 2024 AUM EUR863B

2025-03-13 06:04; UTC

Uždarbis

Analysts Saw Generali 2024 Dividend EUR1.40

2025-03-13 06:04; UTC

Uždarbis

Generali Proposes EUR1.43 Dividend Per Share

2025-03-13 06:04; UTC

Uždarbis

Generali 2024 New Business Margin 4.60%

2025-03-13 06:04; UTC

Uždarbis

Analysts Saw Generali End 2024 Solvency Ratio 211%

2025-03-13 06:04; UTC

Uždarbis

Generali End 2024 Solvency Ratio 210%

2025-03-13 06:04; UTC

Uždarbis

Analysts Saw Generali 2024 Combined Ratio 94.0%

2025-03-13 06:04; UTC

Uždarbis

Generali 2024 Combined Ratio 94.0%

2025-03-13 06:03; UTC

Uždarbis

Analysts Saw Generali 2024 Oper Result EUR7.23B

2025-03-13 06:03; UTC

Uždarbis

Generali 2024 Oper Pft EUR7.295B

2025-03-13 06:03; UTC

Uždarbis

Analysts Saw Generali 2024 Gross Written Premiums EUR94.21B

2025-03-13 06:03; UTC

Uždarbis

Generali 2024 Gross Written Premiums EUR95.19B

2025-03-13 06:03; UTC

Uždarbis

Analysts Saw Generali 2024 Adj. Net Pft EUR3.76B

2025-03-13 06:03; UTC

Uždarbis

Generali 2024 Adj. Net Pft EUR3.77B

2025-03-13 06:03; UTC

Uždarbis

Analysts Saw Generali 2024 Net Pft EUR3.825B

Akcijų palyginimas

Kainos pokytis

Genpact Ltd Prognozė

Kainos tikslas

By TipRanks

17.57% į viršų

12 mėnesių prognozė

Vidutinis 56.22 USD  17.57%

Aukščiausias 58 USD

Žemiausias 55 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Genpact Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

9 ratings

4

Pirkti

5

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

4.6 / 4.8Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.